Downregulation of sulfotransferase expression and activity in diseased human livers

Emine B. Yalcin, Vijay More, Karissa L. Neira, Zhenqiang James Lu, Nathan J Cherrington, Angela L. Slitt, Roberta S. King

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Sulfotransferase (SULT) function has been well studied in healthy human subjects by quantifying mRNA and protein expression and determining enzyme activity with probe substrates. However, it is not well known if sulfotransferase activity changes in metabolic and liver disease, such as diabetes, steatosis, or cirrhosis. Sulfotransferases have significant roles in the regulation of hormones and excretion of xenobiotics. In the present study of normal subjects with nonfatty livers and patients with steatosis, diabetic cirrhosis, and alcoholic cirrhosis, we sought to determine SULT1A1, SULT2A1, SULT1E1, and SULT1A3 activity and mRNA and protein expression in human liver tissue. In general, sulfotransferase activity decreased significantly with severity of liver disease from steatosis to cirrhosis. Specifically, SULT1A1 and SULT1A3 activities were lower in disease states relative to nonfatty tissues. Alcoholic cirrhotic tissues further contained lower SULT1A1 and 1A3 activities than those affected by either of the two other disease states. SULT2A1, on the other hand, was only reduced in alcoholic cirrhotic tissues. SULT1E1 was reduced both in diabetic cirrhosis and in alcoholic cirrhosis tissues, relative to nonfatty liver tissues. In conclusion, the reduced levels of sulfotransferase expression and activity in diseased versus nondiseased liver tissue may alter the metabolism and disposition of xenobiotics and affect homeostasis of endobiotic sulfotransferase substrates.

Original languageEnglish (US)
Pages (from-to)1642-1650
Number of pages9
JournalDrug Metabolism and Disposition
Volume41
Issue number9
DOIs
StatePublished - Sep 2013

Fingerprint

Sulfotransferases
Liver Diseases
Down-Regulation
Fibrosis
Alcoholic Liver Cirrhosis
Liver
Xenobiotics
Messenger RNA
Metabolic Diseases
Fatty Liver
Healthy Volunteers
Proteins
Homeostasis
Hormones
Enzymes

ASJC Scopus subject areas

  • Pharmacology
  • Pharmaceutical Science

Cite this

Downregulation of sulfotransferase expression and activity in diseased human livers. / Yalcin, Emine B.; More, Vijay; Neira, Karissa L.; Lu, Zhenqiang James; Cherrington, Nathan J; Slitt, Angela L.; King, Roberta S.

In: Drug Metabolism and Disposition, Vol. 41, No. 9, 09.2013, p. 1642-1650.

Research output: Contribution to journalArticle

Yalcin, Emine B. ; More, Vijay ; Neira, Karissa L. ; Lu, Zhenqiang James ; Cherrington, Nathan J ; Slitt, Angela L. ; King, Roberta S. / Downregulation of sulfotransferase expression and activity in diseased human livers. In: Drug Metabolism and Disposition. 2013 ; Vol. 41, No. 9. pp. 1642-1650.
@article{7fb81ada811d4bfea235c3b73f0dc9df,
title = "Downregulation of sulfotransferase expression and activity in diseased human livers",
abstract = "Sulfotransferase (SULT) function has been well studied in healthy human subjects by quantifying mRNA and protein expression and determining enzyme activity with probe substrates. However, it is not well known if sulfotransferase activity changes in metabolic and liver disease, such as diabetes, steatosis, or cirrhosis. Sulfotransferases have significant roles in the regulation of hormones and excretion of xenobiotics. In the present study of normal subjects with nonfatty livers and patients with steatosis, diabetic cirrhosis, and alcoholic cirrhosis, we sought to determine SULT1A1, SULT2A1, SULT1E1, and SULT1A3 activity and mRNA and protein expression in human liver tissue. In general, sulfotransferase activity decreased significantly with severity of liver disease from steatosis to cirrhosis. Specifically, SULT1A1 and SULT1A3 activities were lower in disease states relative to nonfatty tissues. Alcoholic cirrhotic tissues further contained lower SULT1A1 and 1A3 activities than those affected by either of the two other disease states. SULT2A1, on the other hand, was only reduced in alcoholic cirrhotic tissues. SULT1E1 was reduced both in diabetic cirrhosis and in alcoholic cirrhosis tissues, relative to nonfatty liver tissues. In conclusion, the reduced levels of sulfotransferase expression and activity in diseased versus nondiseased liver tissue may alter the metabolism and disposition of xenobiotics and affect homeostasis of endobiotic sulfotransferase substrates.",
author = "Yalcin, {Emine B.} and Vijay More and Neira, {Karissa L.} and Lu, {Zhenqiang James} and Cherrington, {Nathan J} and Slitt, {Angela L.} and King, {Roberta S.}",
year = "2013",
month = "9",
doi = "10.1124/dmd.113.050930",
language = "English (US)",
volume = "41",
pages = "1642--1650",
journal = "Drug Metabolism and Disposition",
issn = "0090-9556",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "9",

}

TY - JOUR

T1 - Downregulation of sulfotransferase expression and activity in diseased human livers

AU - Yalcin, Emine B.

AU - More, Vijay

AU - Neira, Karissa L.

AU - Lu, Zhenqiang James

AU - Cherrington, Nathan J

AU - Slitt, Angela L.

AU - King, Roberta S.

PY - 2013/9

Y1 - 2013/9

N2 - Sulfotransferase (SULT) function has been well studied in healthy human subjects by quantifying mRNA and protein expression and determining enzyme activity with probe substrates. However, it is not well known if sulfotransferase activity changes in metabolic and liver disease, such as diabetes, steatosis, or cirrhosis. Sulfotransferases have significant roles in the regulation of hormones and excretion of xenobiotics. In the present study of normal subjects with nonfatty livers and patients with steatosis, diabetic cirrhosis, and alcoholic cirrhosis, we sought to determine SULT1A1, SULT2A1, SULT1E1, and SULT1A3 activity and mRNA and protein expression in human liver tissue. In general, sulfotransferase activity decreased significantly with severity of liver disease from steatosis to cirrhosis. Specifically, SULT1A1 and SULT1A3 activities were lower in disease states relative to nonfatty tissues. Alcoholic cirrhotic tissues further contained lower SULT1A1 and 1A3 activities than those affected by either of the two other disease states. SULT2A1, on the other hand, was only reduced in alcoholic cirrhotic tissues. SULT1E1 was reduced both in diabetic cirrhosis and in alcoholic cirrhosis tissues, relative to nonfatty liver tissues. In conclusion, the reduced levels of sulfotransferase expression and activity in diseased versus nondiseased liver tissue may alter the metabolism and disposition of xenobiotics and affect homeostasis of endobiotic sulfotransferase substrates.

AB - Sulfotransferase (SULT) function has been well studied in healthy human subjects by quantifying mRNA and protein expression and determining enzyme activity with probe substrates. However, it is not well known if sulfotransferase activity changes in metabolic and liver disease, such as diabetes, steatosis, or cirrhosis. Sulfotransferases have significant roles in the regulation of hormones and excretion of xenobiotics. In the present study of normal subjects with nonfatty livers and patients with steatosis, diabetic cirrhosis, and alcoholic cirrhosis, we sought to determine SULT1A1, SULT2A1, SULT1E1, and SULT1A3 activity and mRNA and protein expression in human liver tissue. In general, sulfotransferase activity decreased significantly with severity of liver disease from steatosis to cirrhosis. Specifically, SULT1A1 and SULT1A3 activities were lower in disease states relative to nonfatty tissues. Alcoholic cirrhotic tissues further contained lower SULT1A1 and 1A3 activities than those affected by either of the two other disease states. SULT2A1, on the other hand, was only reduced in alcoholic cirrhotic tissues. SULT1E1 was reduced both in diabetic cirrhosis and in alcoholic cirrhosis tissues, relative to nonfatty liver tissues. In conclusion, the reduced levels of sulfotransferase expression and activity in diseased versus nondiseased liver tissue may alter the metabolism and disposition of xenobiotics and affect homeostasis of endobiotic sulfotransferase substrates.

UR - http://www.scopus.com/inward/record.url?scp=84882755645&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84882755645&partnerID=8YFLogxK

U2 - 10.1124/dmd.113.050930

DO - 10.1124/dmd.113.050930

M3 - Article

VL - 41

SP - 1642

EP - 1650

JO - Drug Metabolism and Disposition

JF - Drug Metabolism and Disposition

SN - 0090-9556

IS - 9

ER -